| A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation. |
36497452 |
Cancers (Basel) |
| AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease. |
40262132 |
Hepatology |
| Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC. |
41316838 |
Liver Int |
| Blood-Based Biomarkers for HCC Surveillance: Ready for the Center Stage? |
37795908 |
Am J Gastroenterol |
| Evaluation of LI-RADS 3 and 4 Lesions. |
39622280 |
Gastroenterology |
| Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients. |
40307890 |
J Exp Clin Cancer Res |
| GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. |
16137783 |
J Hepatol |
| Incidental Findings During Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis. |
40349897 |
Clin Gastroenterol Hepatol |
| Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. |
18045939 |
J Virol |
| Integrative Analysis of Fucosylated Tetra Glycoforms in Hepatocellular Carcinoma: A NanoLC-PRM-MS/MS and Machine Learning Approach. |
41212027 |
J Proteome Res |
| Leveraging multi-cancer blood tests to improve diagnostic efficiency for patients with nonspecific signs and symptoms. |
39193702 |
Future Oncol |
| Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. |
36402450 |
J Hepatol |
| Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinoma. |
40321196 |
JHEP Rep |
| Patient-Perceived Risk of Hepatocellular Carcinoma and Net Benefit of Surveillance: A Multicenter Survey Study. |
40267274 |
Am J Gastroenterol |
| Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis. |
39521255 |
Gastroenterology |
| Risk-stratified surveillance for hepatocellular carcinoma. |
41921193 |
Hepatol Commun |
| SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. |
15726646 |
Hepatology |
| Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. |
39652379 |
Hepatol Commun |
| Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma. |
39627514 |
Commun Med (Lond) |
| Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. |
37129867 |
Liver Transpl |
| Temporal Changes in Risk Factors of Hepatocellular Carcinoma in a Prospective Cirrhosis Cohort. |
39694208 |
Clin Gastroenterol Hepatol |
| The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance. |
38742973 |
Radiology |
| Very Early-Stage Detection Is Associated With Improved Survival in Patients With Unifocal Hepatocellular Carcinoma. |
41173809 |
Aliment Pharmacol Ther |
